Clinical Trials List
2012-05-23 - 2015-12-31
Phase III
Terminated3
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- Been Ren Lin Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Hao-Wei Teng Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- 張世慶 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
200 participants
